Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.

Through genome-wide association analysis and an independent replication study using a total of 1131 bladder cancer cases and 12 558 non-cancer controls of Japanese populations, we identified a susceptibility locus on chromosome 15q24. SNP rs11543198 was associated with bladder cancer risk with odds ratio (OR) of 1.41 and P-value of 4.03 × 10(-9). Subgroup analysis revealed rs11543198 to have a stronger effect in male smokers with OR of 1.66. SNP rs8041357, which is in complete linkage disequilibrium (r(2) = 1) with rs11543198, was also associated with bladder cancer risk in Europeans (P = 0.045 for an additive and P = 0.025 for a recessive model), despite much lower minor allele frequency in Europeans (3.7%) compared with the Japanese (22.2%). Imputational analysis in this region suggested CYP1A2, which metabolizes tobacco-derived carcinogen, as a causative candidate gene. We also confirmed the association of previously reported loci, namely SLC14A1, APOBEC3A, PSCA and MYC, with bladder cancer. Our finding implies the crucial roles of genetic variations on the chemically associated development of bladder cancer.

[1]  Jianfeng Xu,et al.  Cumulative effect of genome‐wide association study‐identified genetic variants for bladder cancer , 2014, International journal of cancer.

[2]  William Wheeler,et al.  Genome-wide association study identifies multiple loci associated with bladder cancer risk. , 2014, Human molecular genetics.

[3]  Jianfeng Xu,et al.  Genetic score of multiple risk‐associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer , 2014, Genes, chromosomes & cancer.

[4]  W. Guo,et al.  RETRACTED ARTICLE: CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: A meta-analysis , 2014, Tumor Biology.

[5]  Xianghua Liu,et al.  Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[6]  Lin Zhao,et al.  Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies. , 2013, Gene.

[7]  Xian-Tao Zeng,et al.  Meta-analysis of the CYP1A2 -163C>A polymorphism and lung cancer risk. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[8]  J. Stockman,et al.  Association Between Smoking and Risk of Bladder Cancer Among Men and Women , 2013 .

[9]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[10]  M. Thun,et al.  Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk , 2012, Proceedings of the National Academy of Sciences.

[11]  Yusuke Nakamura,et al.  A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population , 2012, Nature Genetics.

[12]  Paolo Vineis,et al.  European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. , 2011, Human molecular genetics.

[13]  Jian Gu,et al.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. , 2011, Human molecular genetics.

[14]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[15]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[16]  William Wheeler,et al.  A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci , 2010, Nature Genetics.

[17]  Yusuke Nakamura,et al.  Genome-wide association study of hematological and biochemical traits in a Japanese population , 2010, Nature Genetics.

[18]  Q. Wei,et al.  Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population. , 2009, Carcinogenesis.

[19]  Jian Gu,et al.  Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[20]  F. Guengerich.  Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[21]  N. Malats,et al.  Risk of Bladder Cancer Associated with Family History of Cancer: Do Low-Penetrance Polymorphisms Account for the Increase in Risk? , 2007, Cancer Epidemiology Biomarkers & Prevention.

[22]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[23]  H. Vainio,et al.  Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver , 2007, Archives of Toxicology.

[24]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[25]  J. V. Moran,et al.  Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Zlotta.  NAT2 Slow Acetylation, GSTM1 Null Genotype, and Risk of Bladder Cancer: Results from the Spanish Bladder Cancer Study and Meta-Analyses , 2006 .

[27]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[28]  M. Kogevinas,et al.  NAT 2 slow acetylation , GSTM 1 null genotype , and risk of bladder cancer : results from the Spanish Bladder Cancer Study and meta-analyses , 2005 .

[29]  L. Loeb,et al.  Environmental and chemical carcinogenesis. , 2004, Seminars in cancer biology.

[30]  D. Silverman,et al.  Occupation and Bladder Cancer Risk in a Population-based Case-control Study in New Hampshire , 2004, Cancer Causes & Control.

[31]  J. Chang-Claude,et al.  Occupation and bladder cancer among men in Western Europe , 2003, Cancer Causes & Control.

[32]  M. Kogevinas,et al.  Environmental exposure, chlorinated drinking water, and bladder cancer , 2004, World Journal of Urology.

[33]  D. Hein.  Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. , 2002, Mutation research.

[34]  L. Kiemeney,et al.  Familial aggregation of urothelial cell carcinoma , 2002, International journal of cancer.

[35]  S R Tannenbaum,et al.  Gender- and smoking-related bladder cancer risk. , 2001, Journal of the National Cancer Institute.

[36]  M. Loda,et al.  Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer , 2000, Oncogene.

[37]  J. Yokota,et al.  Detection of Three Genetic Polymorphisms in the 5′‐Flanking Region and Intron 1 of Human CYP1A2 in the Japanese Population , 1999, Japanese journal of cancer research : Gann.

[38]  T. Kamataki,et al.  Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. , 1999, Journal of biochemistry.

[39]  J. Lewtas,et al.  Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. , 1997, Mutation research.

[40]  A. DeCaprio,et al.  Biomarkers : Coming of age for environmental health and risk assessment , 1997 .

[41]  P. O'connor,et al.  Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[42]  A. Risch,et al.  Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. , 1995, Human molecular genetics.

[43]  T. Kamataki,et al.  Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  F. Guengerich,et al.  Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. , 1994, Toxicology letters.

[45]  A. Boobis,et al.  CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. , 1994, Cancer research.

[46]  S. Manabe,et al.  Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate. , 1991, Carcinogenesis.

[47]  T. Kuo,et al.  ARSENIC AND CANCERS , 1988, The Lancet.

[48]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[49]  J. Harman.  Letter: Realistic goals for smoking and health. , 1974, The Lancet.